Avoplacel

N/A

Report date: 2023/04/03 12:33:07

Base Information

Drug NameAvoplacel
Drug Alias NamePLX R 18PLX RADPLX R-18PLX-RADPLX-R-18
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapy
Mechanisms of ActionCell differentiation modulatorsBone marrow cells stimulantsStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsGraft vs Host DiseaseAnemia, Aplastic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesFukushima Medical UniversityPluristem Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesHemafund LtdPluristem Therapeutics IncFukushima Medical University +[4] 
Inactive CompaniesN/A
Active IndicationsGraft vs Host DiseaseAnemia, Aplastic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A